Published in Vet Immunol Immunopathol on September 01, 1987
In vivo lymphocyte tropism of feline immunodeficiency virus. J Virol (1993) 2.00
Feline immunodeficiency virus predisposes cats to acute generalized toxoplasmosis. Am J Pathol (1993) 1.12
A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction. J Virol (1996) 0.99
Molecularly cloned feline immunodeficiency virus NCSU1 JSY3 induces immunodeficiency in specific-pathogen-free cats. J Virol (1996) 0.95
Evidence for CD8+ antiviral activity in cats infected with feline immunodeficiency virus. J Virol (1996) 0.89
Feline glycoprotein A repetitions predominant anchors transforming growth factor beta on the surface of activated CD4(+)CD25(+) regulatory T cells and mediates AIDS lentivirus-induced T cell immunodeficiency. AIDS Res Hum Retroviruses (2013) 0.85
CD8+ clonality is associated with prolonged acute plasma viremia and altered mRNA cytokine profiles during the course of feline immunodeficiency virus infection. Vet Immunol Immunopathol (2012) 0.76
Isolation and characterization of three subpopulations of IgG in the common cat (Felis catus). Immunology (1994) 0.75
Modulating DNA methylation in activated CD8+ T cells inhibits regulatory T cell-induced binding of Foxp3 to the CD8+ T Cell IL-2 promoter. J Immunol (2014) 0.75
Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia (2003) 3.89
Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J (2005) 3.84
Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry (2008) 3.28
Herpesvirus type 2: association with carcinoma of the cervix. Science (1968) 3.03
Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia (2003) 2.89
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia (2004) 2.76
The association of herpesvirus type 2 and carcinoma of the uterine cervix. Am J Epidemiol (1969) 2.74
Sickness behavior as a new target for drug development. Trends Pharmacol Sci (1992) 2.42
CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry (2009) 2.36
A new concept in neurodegeneration: TNFalpha is a silencer of survival signals. Trends Neurosci (2000) 1.93
A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc Natl Acad Sci U S A (1999) 1.90
Interleukin-10 in the brain. Crit Rev Immunol (2001) 1.89
Cultural and antigenic properties of newly established cell strains derived from adenocarcinomas of the human colon and rectum. J Natl Cancer Inst (1974) 1.86
Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors. Oncogene (2008) 1.73
Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sci (1989) 1.70
Body surface area of female swine. J Anim Sci (1973) 1.70
An in vitro measure of cellular immunity to fibroma virus. J Immunol (1970) 1.58
Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999). J Am Vet Med Assoc (2001) 1.56
Differential effects of kinase cascade inhibitors on neoplastic and cytokine-mediated cell proliferation. Leukemia (2003) 1.56
A novel role of growth hormone and insulin-like growth factor-I. Priming neutrophils for superoxide anion secretion. J Immunol (1991) 1.55
Development of clinical disease in cats experimentally infected with feline immunodeficiency virus. J Infect Dis (1994) 1.53
Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. Leukemia (2011) 1.51
Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. Proc Natl Acad Sci U S A (1992) 1.49
A review of the biological properties and metabolic disposition of the new analgesic agent, meptazinol. Gen Pharmacol (1978) 1.47
The pharmacokinetics of ciclazindol (Wy 23409) in human volunteers. Br J Clin Pharmacol (1977) 1.44
Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent? Auton Neurosci (2000) 1.41
Cimetidine for treatment of melanomas in three horses. J Am Vet Med Assoc (1990) 1.41
Molecular basis of sickness behavior. Ann N Y Acad Sci (1998) 1.39
Requirement for phosphatidylinositol 3'-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor. J Immunol (1996) 1.39
Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Res (1992) 1.37
Aging sensitizes mice to behavioral deficits induced by central HIV-1 gp120. Neurobiol Aging (2006) 1.33
Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. C R Acad Sci III (1994) 1.33
IL-10 inhibits apoptosis of promyeloid cells by activating insulin receptor substrate-2 and phosphatidylinositol 3'-kinase. J Immunol (2001) 1.33
Cytokines and sickness behavior. Ann N Y Acad Sci (1998) 1.32
Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice. Psychoneuroendocrinology (1994) 1.31
Treatment of thyroid carcinoma in dogs by surgical resection alone: 20 cases (1981-1989). J Am Vet Med Assoc (1995) 1.30
Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats. Psychoneuroendocrinology (1999) 1.28
Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle. J Cell Physiol (1993) 1.25
GH3 pituitary adenoma cells can reverse thymic aging in rats. Proc Natl Acad Sci U S A (1986) 1.24
Congenital malformation of the central nervous system associated with genital type (type 2) herpesvirus. J Pediatr (1969) 1.24
Prolactin synthesized and secreted by human peripheral blood mononuclear cells: an autocrine growth factor for lymphoproliferation. Proc Natl Acad Sci U S A (1992) 1.23
Characterization of monoclonal antibodies to feline T lymphocytes and their use in the analysis of lymphocyte tissue distribution in the cat. Vet Immunol Immunopathol (1990) 1.23
Rapamycin inhibits the phosphorylation of p70 S6 kinase in IL-2 and mitogen-activated human T cells. Biochem Biophys Res Commun (1992) 1.23
ts1, a Paralytogenic mutant of Moloney murine leukemia virus TB, has an enhanced ability to replicate in the central nervous system and primary nerve cell culture. J Virol (1985) 1.21
Newcastle disease virus as an antineoplastic agent: induction of tumor necrosis factor-alpha and augmentation of its cytotoxicity. J Natl Cancer Inst (1988) 1.20
Failure of rapamycin to block proliferation once resting cells have entered the cell cycle despite inactivation of p70 S6 kinase. J Biol Chem (1993) 1.19
Cellular deoxyribonucleic acid synthesis and loss of contact inhibition in irradiated and contact-inhibited cell cultures infected with fibroma virus. J Virol (1969) 1.19
Lessons from the cat: feline immunodeficiency virus as a tool to develop intervention strategies against human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (1998) 1.19
Specific macrophage immunity to vaccinia virus: macrophage-virus interaction. Infect Immun (1972) 1.19
Passive smoking and canine lung cancer risk. Am J Epidemiol (1992) 1.15
Canine bladder and urethral tumors: a retrospective study of 115 cases (1980-1985). J Vet Intern Med (1992) 1.15
Macrophage activation in congenitally athymic mice raised under conventional or germ-free conditions. J Reticuloendothel Soc (1977) 1.14
Stress and immune function: a bibliographic review. Ann Rech Vet (1980) 1.12
Newcastle disease virus-infected splenocytes express the proopiomelanocortin gene. J Exp Med (1986) 1.10
Vagotomy blocks behavioural effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes. Neuroreport (1996) 1.09
Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs. Leukemia (1999) 1.09
Feline lymphoma (145 cases): proliferation indices, cluster of differentiation 3 immunoreactivity, and their association with prognosis in 90 cats. J Vet Intern Med (1998) 1.09
Central administration of insulin-like growth factor-1 inhibits lipopolysaccharide-induced sickness behavior in mice. Neuroreport (1999) 1.09
Effects of aerial ammonia, hydrogen sulfide and swine-house dust on rate of gain and respiratory-tract structure in swine. J Anim Sci (1975) 1.07
Role of the Raf signal transduction cascade in the in vitro resistance to the anticancer drug doxorubicin. Clin Cancer Res (2001) 1.06
A newly defined property of somatotropin: priming of macrophages for production of superoxide anion. Science (1988) 1.06
Amputation and cisplatin for treatment of canine osteosarcoma. J Vet Intern Med (1991) 1.05
Thymoma in dogs: 23 cases (1980-1991). J Am Vet Med Assoc (1994) 1.05
Diurnal and annual fluctuations of aerial bacterial and dust levels in enclosed swine houses. J Anim Sci (1975) 1.04
Feline immunodeficiency virus can be experimentally transmitted via milk during acute maternal infection. J Virol (1994) 1.04
Lipopolysaccharide and interleukin-1 depress food-motivated behavior in mice by a vagal-mediated mechanism. Brain Behav Immun (1995) 1.04
Studies on the metabolism of meptazinol, a new analgesic drug. Br J Clin Pharmacol (1976) 1.03
Infection of the choroid plexus by feline immunodeficiency virus. J Neurovirol (2002) 1.03
Interferon-gamma-induced priming for secretion of superoxide anion and tumor necrosis factor-alpha declines in macrophages from aged rats. FASEB J (1990) 1.03
Pharmacokinetic studies on WY 23409 HCl. Br J Clin Pharmacol (1975) 1.03
Prophylactic trimethoprim-sulfadiazine during chemotherapy in dogs with lymphoma and osteosarcoma: a double-blind, placebo-controlled study. J Vet Intern Med (2007) 1.02
Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995). J Am Vet Med Assoc (1997) 1.02
Growth hormone augments superoxide anion secretion of human neutrophils by binding to the prolactin receptor. J Clin Invest (1992) 1.01
Swine influenza virus in swine and man in Illinois. J Occup Med (1981) 1.01
Murine macrophages express abundant insulin-like growth factor-I class I Ea and Eb transcripts. Endocrinology (1993) 1.01
Interleukin-1 mediates behavioural but not metabolic effects of tumor necrosis factor alpha in mice. Eur J Pharmacol (1991) 1.01
The classification of benzodiazepine hypnotics. Br J Clin Pharmacol (1983) 1.00
Cytotoxic macrophages induced in hamsters by vaccinia virus: selective cytotoxicity for virus-infected targets by macrophages collected late after immunization. J Immunol (1979) 0.99
Mechanisms of sickness-induced decreases in food-motivated behavior. Neurosci Biobehav Rev (1996) 0.99
Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally. Neuroreport (1996) 0.98
Macrophage immunity to vaccina virus: factors affecting macrophage immunity in vitro. J Reticuloendothel Soc (1974) 0.98
Central and peripheral prostaglandins are involved in sickness behavior in birds. Physiol Behav (1993) 0.98
Stress-induced alterations in delayed-type hypersensitivity to SRBC and contact sensitivity to DNFB in mice. Proc Soc Exp Biol Med (1982) 0.98
Resolution of paraneoplastic leukocytosis and hypertrophic osteopathy after resection of a renal transitional cell carcinoma producing granulocyte-macrophage colony-stimulating factor in a young Bull Terrier. J Vet Intern Med (2001) 0.98
A conditionally-active form of MEK1 results in autocrine tranformation of human and mouse hematopoietic cells. Oncogene (2000) 0.98
In vivo and in vitro evidence for the involvement of tumor necrosis factor-alpha in the induction of leptin by lipopolysaccharide. Endocrinology (1998) 0.97
Differential effects of IL-1ra on sickness behavior and weight loss induced by IL-1 in rats. Brain Res (1995) 0.97
Role of interferon-gamma in counteracting the suppressive effects of transforming growth factor-beta 2 and glucocorticoids on the production of tumor necrosis factor-alpha. J Leukoc Biol (1990) 0.97
The pituitary gland is required for protection against lethal effects of Salmonella typhimurium. Proc Natl Acad Sci U S A (1991) 0.97
Characterization of surface antigen on cells infected by fibroma virus. J Immunol (1970) 0.97
C3H/HeJ mice are refractory to lipopolysaccharide in the brain. Brain Res (1997) 0.96
Lymphocyte and macrophage responses after vaccinia virus infections. Infect Immun (1976) 0.96
Enhanced cytotoxicity of mouse natural killer cells for vaccinia and herpes virus-infected targets. J Reticuloendothel Soc (1980) 0.96
Molecularly cloned feline immunodeficiency virus NCSU1 JSY3 induces immunodeficiency in specific-pathogen-free cats. J Virol (1996) 0.95
Expression and localization of p80 and p68 interleukin-1 receptor proteins in the brain of adult mice. J Neuroimmunol (1999) 0.95
Activation of protein kinase C-zeta and phosphatidylinositol 3'-kinase and promotion of macrophage differentiation by insulin-like growth factor-I. J Immunol (1998) 0.95
Reduction in food and water intake induced by microinjection of interleukin-1 beta in the ventromedial hypothalamus of the rat. Physiol Behav (1994) 0.94
Mechanisms of the behavioural effects of cytokines. Adv Exp Med Biol (1999) 0.94
Photodestruction of tumor cells by induction of endogenous accumulation of protoporphyrin IX: enhancement by 1,10-phenanthroline. Photochem Photobiol (1992) 0.94
Absence of lithium-induced taste aversion after area postrema lesion. Brain Res (1980) 0.94